Chemspeed and SciY Announce Self?Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
MWN-AI** Summary
Chemspeed Technologies and SciY have announced the launch of their Self-Driving Lab (SDL) platform during SLAS2026, aimed at revolutionizing research and development (R&D), quality control (QC), and manufacturing workflows in laboratories. This innovative platform integrates automation, analytics, and AI orchestration, enabling laboratory managers to conduct autonomous experiments seamlessly. The SDL supports modular precision automation and vendor-agnostic lab management, providing a cohesive digital infrastructure that enhances efficiency in data handling and operational workflows.
Today's laboratories are often hindered by the siloed nature of their existing tools, resulting in integration issues and inefficient processes. The SDL platform addresses these challenges by offering a unified framework that connects various hardware and software systems, ensuring compatibility and operational integrity. This integration fosters a continuous and streamlined workflow, facilitating faster discovery and quality control processes.
Chemspeed’s precision automation capabilities empower labs with reproducible execution of complex workflows, while SciY's AI-ready data backbone consolidates data from diverse sources in accordance with FAIR principles (Findable, Accessible, Interoperable, Reusable). This synergy not only supports better decision-making but also enhances the scalability of laboratory operations.
Chemspeed's President, Bernd Gleixner, emphasized the importance of vendor-agnostic orchestration, which promotes a closed-loop cycle of design, testing, and analysis for 24/7 laboratory operations. SciY's President, Santi Dominguez, noted the growing interest from pharmaceutical partners, confirming the demand for adaptable and deployable SDLs to support autonomous lab operations across various use cases.
With a focus on accelerating innovation and improving product quality, the SDL platform heralds a new era in laboratory efficiency and AI integration.
MWN-AI** Analysis
Chemspeed Technologies and SciY's recent announcement of their Self-Driving Laboratory (SDL) platform marks a significant advancement in laboratory automation and digital transformation, with implications for the pharmaceutical and biotech sectors. As the SDL integrates automation, AI orchestration, and analytics, it stands to address existing challenges that laboratories face in terms of siloed systems and inefficiencies.
From a financial perspective, investors should consider the following key points:
1. **Market Demand**: The introduction of a vendor-agnostic platform aligns with growing demand for interoperable and scalable solutions in R&D and quality control. The emphasis on automation and AI readiness is particularly resonant as industries strive for operational excellence. As Chemspeed and SciY attract interest from top pharmaceutical companies, this strengthens their market position.
2. **Operational Efficiency**: The SDL's closed-loop functionality facilitates continuous operations, significantly reducing time-to-market for drug development and improving workflow efficiency. Companies that can adopt such technologies are likely to see enhanced productivity and cost reductions in the long term, making them attractive investments.
3. **Strategic Partnerships**: Collaborations with major pharma partners not only validate the SDL’s utility but also open avenues for further scalability and sales growth. Investors should keep an eye on how these partnerships evolve, as they can impact revenue streams positively.
4. **Competitive Advantage**: The combination of Chemspeed's precision automation with SciY's data management capabilities creates a formidable competitive edge. As laboratories increasingly transition to AI-enhanced environments, companies able to provide comprehensive digital solutions will be well-positioned in a rapidly evolving market landscape.
In conclusion, given the SDL platform’s potential to revolutionize laboratory workflows, investors would be prudent to monitor Chemspeed and SciY closely, considering them as strong candidates for growth in the automation sector of the life sciences industry.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
At SLAS2026 , Chemspeed Technologies , a leader in the automation and digitalization of R&D and QC laboratories, and SciY , a leader in scientific and laboratory management software focused on lab standardization and AI-readiness, today introduce their open Self?Driving Lab (SDL) platform. Their Self-Driving Lab platform is designed to accelerate research and development (R&D), quality control (QC) and chemical and biomolecular manufacturing workflows. The SDL enables lab managers to operationalize autonomous, AI?orchestrated experimentation through vendor?agnostic integration that unites modular precision automation, scientific analysis and lab management software, complete lab digitization and an AI?ready open data backbone.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209464493/en/
The Chemspeed/SciY Self?Driving Lab (SDL) platform integrates vendor?agnostic R&D and QC lab automation, scientific and lab management software, lab digitization and AI?orchestration on an open backbone to increase throughput and quality across value chains
Today, many labs face significant challenges from siloed tools and integration gaps in heterogeneous lab environments that limit efficiency and scalability. The diversity of hardware and software systems often results in incomplete connectivity, incompatible data formats, and fragmented workflows. These constraints slow discovery, development and manufacturing QC processes, and hinder the transition towards autonomous AI?enabled operations.
The Chemspeed/SciY open SDL platform provides this digital lab foundation and integrates the laboratory environment. Outstanding analytics, for NMR, IR/Raman, MS and X?ray, ensures the traceable, quantitative data required in critical decisions. Chemspeed’s precision automation delivers modular, vendor?agnostic control over complex laboratory workflows with deterministic, reproducible execution. SciY’s AI?ready open data backbone unifies instruments and robotics data, workflow automation and orchestration with vendor?agnostic FAIR (Findable, Accessible, Interoperable, Reusable) data capture, curation, governance and ontology?driven semantics.
“Vendor?agnostic orchestration is key. With our open SDL, we enable decision?making in closed?loop design–make–test–analyze (DMTA) workflows towards continuous 24/7 operations,” said Bernd Gleixner, the President of Chemspeed. “We are delivering not only a platform, but a service engine that accelerates discovery, supports compliant scale?up and increases throughput across customers’ value chains.”
“We are seeing strong market interest by leading pharmaceutical partners,” said Santi Dominguez, the President of SciY. “This confirms that customers are looking for open, readily deployable full stack SDLs, and we are partnering with them to scale autonomous operations across sites and use cases.”
Chemspeed and SciY are vendor-agnostics divisions of Bruker Corporation (Nasdaq: BRKR).
About Chemspeed
Chemspeed Technologies, a Bruker division, empowers scientists and engineers to accelerate discovery, development, and QC (including regulated markets) with modular robotics, automation platforms and standardized systems across the laboratory workflow. From single function benchtop systems to integrated, vendor agnostic self-driving labs, Chemspeed solutions address complex tasks in synthesis, compound management, sample preparation, formulation, and testing, and are designed for closed loop, AI-ready operations that improve data quality and productivity. For over 25 years, Chemspeed has served R&D and QC organizations in pharma & biotech, materials science, energy/battery, and consumer goods, and is headquartered in Switzerland. For more information, please visit: www.chemspeed.com
About SciY
SciY, a Bruker division, provides vendor?agnostic digitalization and orchestration solutions that connect scientific instrumentation, automation hardware, and information systems across research, development, and GMP manufacturing. Our platform connects these systems and their data into a unified digital environment where information is ingested, standardized, re?used and preserved according to FAIR principles. SciY combines expertise in data analysis, knowledge extraction, and automation with AI-powered experimentation to streamline traditionally time?consuming processes. The result is an integrated, governed, and scalable environment to accelerate innovation, harmonize operations, de-risk scale-up and drive products to market faster with consistent quality. For more information, visit www.sciy.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20260209464493/en/
Media Contact:
Markus Ziegler
Sr. Director and Head of Group Marketing, Bruker BioSpin
T: +49 172 3733531
E: info@sciy.com
FAQ**
How does the integration of Chemspeed and SciY's SDL platform enhance the capabilities of Bruker Corporation BRKR in the competitive landscape of lab automation and AI-driven research?
What specific challenges in current lab environments does the open SDL platform aim to address for Bruker Corporation BRKR's clients, and how does it facilitate faster decision-making?
In what ways does the vendor-agnostic nature of the SDL platform position Bruker Corporation BRKR to attract partnerships with leading pharmaceutical companies seeking innovative lab solutions?
How does the adoption of the SDL platform by clients impact Bruker Corporation BRKR's long-term growth strategy, particularly in the areas of R&D and quality control?
**MWN-AI FAQ is based on asking OpenAI questions about Bruker Corporation (NASDAQ: BRKR).
NASDAQ: BRKR
BRKR Trading
-4.2% G/L:
$33.77 Last:
1,757,075 Volume:
$35.44 Open:
